P.S I think what will ruin the company is the fact that when a...

P.S I think what will ruin the company is the fact that when a company does there due diligence when deciding whether to possibly help cbio commercialise, they will see possible insider trading has taken place and may run a mile. With all the complaints, I'd say ASIC would most likely be investigating. Where is Cameron's explanation to what happened?

They'd want to also know why Ando, and Longren resigned after being forced to work with the current board. Ando is very very very well respected in drug development. At present, the only director with medical experience who wants to work with Cameron, is Cameron herself.

Instead of giving half baked facts Lethalone, I suggest you give logical ones.